Blog Posts

21 Feb 2017
75% Americans Agree with Trump: Drug Prices Are Too High
  • Posted at: 15:28h
  • Posted by:
  • Comments: 0
  • Tag:

[vc_row][vc_column][vc_column_text]

block_2

According to a new Zogby Poll, 75% of Americans agree with President Trump that the pharmaceutical industry is “getting away with murder” on drug prices. While Republican members of Congress have prioritized the dismantling of Obamacare, the majority of Americans, both Republican and Democrats alike, are clearly concerned about prescription drug costs.  The poll shows that 79 percent of Americans believe drug prices are too high, while nearly 52 percent believe the pharmaceutical industry is price gouging and putting profits over patients.

There is a clearly a public health crisis. Too many Americans are going without necessary medications because of their skyrocketing costs. This new poll shows the serious effects of exorbitant drug prices on consumers: because of costs, nearly 1 in 3 Americans say they have gone without medication and 1 in 4 have had to choose between medication and a necessity like food or housing.

(more…)

06 Feb 2017
img

Today, Prescription Justice issued a press release announcing new data showing that 45 million Americans did not fill a prescription in 2016 because of drug costs and the publication of its policy report recommending that President Donald Trump take executive actions to help consumers more easily import lower cost medications for personal use. Previously, Prescription Justice reported that 35 million American adults did not fill a prescription because of cost. The new data, extracted from the Commonwealth Fund’s 2016 International Health Policy Survey of Adults, shows the crisis of high drug prices to be worse than is widely reported. (more…)

30 Jan 2017
img

We are proud to announce that we have changed our organization's (DBA) name from Prescription Justice Action Group to Prescription Justice, which is a simpler expression of our core position: making prescription drugs affordable is an issue of justice for Americans and we will help them obtain it.

In addition to our website and logo redesign, we have also added a weekly media update that features top news and journal articles focused on our policy priorities - personal drug importation, Medicare Drug Price Negotiations, and ending "Pay for Delay", - as well as other advocacy efforts about tackling the prescription drug price crisis in America and globally.

Let's all work together to bring about prescription justice!

21 Jan 2017
img

Last week, Senators Bernie Sanders (I-VT) and Amy Klobuchar (D-MN) proposed an amendment (S.A. 178) to the Senate Budget Reconciliation bill that would allow individuals, pharmacies and wholesalers to import prescription medications from Canada and other countries with a valid prescription from a U.S. provider.

The amendment took place during a 7-hour vote-a-rama in which more than 150 amendments were considered and voted on for a brief ten minutes.  The amendment failed 52-46, with 13 Democrats voting against it. While the measure failed to pass, it surprisingly garnered support from 12 Republicans including Senators Ted Cruz and Rand Paul. It’s worth noting that Senators Chuck Schumer (D-NY) and Kristen Gillibrand (D-NY) voted against the Dorgan-Snowe importation amendment in 2009, voted yes this time around. (more…)

06 Jan 2017
img

Value-based pharmaceutical pricing, aimed at achieving better value for pharmaceutical spending and lowering drug prices, while maintaining innovation, is a concept that is gaining traction.  In the U.S., prescription drug prices are set by pharmaceutical companies to maximize profits, not based on how well a drug works. In contrast, according to its proponents, value-based drug pricing would mean real health outcomes (not just profits) determine the cost of a drug.  

President-Elect Trump’s push for healthcare reform that focuses on free market, consumer-driven initiatives will enhance the political viability of value-based drug pricing. It has more support by the pharmaceutical industry than other popular policies to bring down drug prices, as it’s viewed as more in line with free market principles than other policy proposals, such as allowing Medicare to negotiate drug prices. 

(more…)